T1 Condition 225 231 Tumors
T2 Intervention 816 823 samples
T3 Condition 678 684 tumors
T4 Gene 949 992 major histocompatibility complex-I binders 
T5 Condition 65 91 Cancer Genome Atlas cancer
T6 Intervention 292 299 samples
T7 Protein 633 657 ≈930 exon-exon junctions
T9 Condition 791 815 breast and ovarian tumor
T10 Gene 164 172 variants
T11 Gene 437 491 U2AF1 and identified additional trans-acting variants 
T12 Protein 427 432 SF3B1
T13 Condition 678 683 tumor
T14 Condition 912 917 tumor
T15 Intervention 598 605 samples
T16 Condition 158 163 tumor
T17 Gene 482 490 variants
T18 Organism 103 117 8,705 patients
T19 Protein 196 207 whole-exome
T20 Condition 520 525 tumor
T21 Condition 225 230 Tumor
T22 Condition 520 526 tumors
T23 Gene 333 341 variants
T24 Protein 188 191 RNA
T25 Condition 838 924 ≈1.7 neojunction- and ≈0.6 single nucleotide variant-derived peptides per tumor sample
T26 Condition 746 751 Tumor
T27 Gene 415 423 variants
